undamentalytics Newsletter
Sign in

Strata Critical Medical, Inc. revenue

Strata Critical Medical, Inc.'s revenue was $197m in fiscal 2025, up 34.3% on the year before. Since fiscal 2019 ($31.2m) it has grown at a compound 36.0% a year. Over the last twelve months it was $281m.

Revenue history

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2019Sept 20192020Sept 20202021Sept 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025LTMSept 2026
Revenue312351146225147197281
Growth on the year before—−24.9%+115.6%+189.2%+54.1%−34.8%+34.3%—
Gross profit52112242304161

Revenue as reported in the company's 10-K and 10-Q filings (for banks, net interest income plus non-interest income). Growth is left blank when the earlier figure was zero or negative.

Where the revenue comes from

Fiscal year to December 31, 2025
Segments
Line of business Revenue Share YoY
Logistics $177M 89.7% ▲ 20.4%
Clinical $20.3M 10.3% —

From Strata Critical Medical, Inc.'s 10-K filed March 3, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Revenue against peers

Health Care Services: the closest covered companies by revenue. Last twelve months.

CompanyRevenueGrowth3-year growth a year
Strata Critical Medical, Inc. $281m 68.4% 9.2%
Docgo Inc. $295m -32.4% -13.3%
Viemed Healthcare, Inc. $302m 25.2% 24.5%
DLH Holdings Corp. $254m -29.5% -9.5%
SBC Medical Group Holdings Inc $175m -6.9% —
Petmed Express Inc $169m -20.3% -13.0%

Compare with peers

Head to head: DCGO vs SRTASRTA vs VMDDLHC vs SRTA

More: Health Care Services stocks compared, Health Care sector, rankings of US companies

Figures from Strata Critical Medical, Inc.'s SEC filings (10-K and 10-Q), retrieved November 3, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Strata Critical Medical, Inc.